| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/19/2001 | WO2001019846A8 Transgenically produced fusion proteins |
| 04/19/2001 | WO2001018218B1 Expression of proteins in genetically modified fungi |
| 04/19/2001 | WO2001014557B1 Pd-1, a receptor for b7-4, and uses therefor |
| 04/19/2001 | WO2001007572A3 Dna recombination in eukaryotic cells by the bacteriophage phic31 recombination system |
| 04/19/2001 | WO2001002565A3 Secreted protein zacrp4 |
| 04/19/2001 | WO2001002554A3 Method for high-throughput selection of interacting molecules |
| 04/19/2001 | WO2000078986B1 Regulation system of expression using nuclear ppar receptors |
| 04/19/2001 | WO2000077232A8 Promoters from atlantic salmon |
| 04/19/2001 | WO2000076309A3 Non-human transgenic animals deficient in gas6 function and their use |
| 04/19/2001 | WO2000071078A3 Composition designed for implementing an antitumoral or antiviral treatment in a mammal |
| 04/19/2001 | WO2000070086A9 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
| 04/19/2001 | WO2000068380A3 Extracellular matrix and adhesion-associated proteins |
| 04/19/2001 | WO2000066730A3 Laminin 2 and methods for its use |
| 04/19/2001 | WO2000065073A3 Genetic sequence which codes for the flavon synthase ii enzyme and use of the same |
| 04/19/2001 | WO2000065036A3 Overexpression of a dna sequence coding for a 1-desoxy-d-xylulose-5-phosphate reductoisomerase in plants |
| 04/19/2001 | WO2000060061A3 Transgenic plant resistant to mycotoxins and methods |
| 04/19/2001 | WO2000060060A3 Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
| 04/19/2001 | WO2000058458A3 Method of producing a randomly primed cdna suitable for targeted cloning |
| 04/19/2001 | WO2000054573A8 Geminivirus resistant transgenic plants |
| 04/19/2001 | WO2000053753A3 Promotion or inhibition of angiogenesis and cardiovascularization |
| 04/19/2001 | WO2000034304A9 Eosinophil-specific expression of transgenes |
| 04/19/2001 | WO2000033161A9 Methods to reduce variance in treatment studies using genotyping |
| 04/19/2001 | WO2000032792A9 Plant 1-deoxy-d-xylulose 5-phosphate synthase |
| 04/19/2001 | WO2000032047A9 Plasmid maintenance system for antigen delivery |
| 04/19/2001 | WO2000030437A8 Transgenic animals |
| 04/19/2001 | WO2000029623A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 04/19/2001 | WO2000029444A9 Generation of antibodies using polynucleotide vaccination in avian species |
| 04/19/2001 | WO2000026245A3 Human membrane transport proteins |
| 04/19/2001 | WO2000012720A9 Elongase genes and uses thereof |
| 04/19/2001 | WO2000005373A9 Methods and compositions for the diagnosis and treatment of body weight disorders, including obesity |
| 04/19/2001 | WO1999051188A3 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| 04/19/2001 | DE19947668A1 Tumorspezifischer Vektor für die Gentherapie A tumor-specific vector for gene therapy |
| 04/19/2001 | DE19947290A1 Verfahren zur Herstellung proteinöser Substanzen A process for preparing proteinaceous substances |
| 04/19/2001 | DE19943383A1 Regulatorische Sequenzen und Expressionskassetten für Hefen Regulatory sequences and expression cassettes for yeasts |
| 04/19/2001 | DE19941871A1 Vorrichtung und Verfahren zum Aufbringen einer Mehrzahl von Mikrotröpfchen auf ein Substrat Apparatus and method for applying a plurality of microdroplets onto a substrate |
| 04/19/2001 | DE10039844A1 New vector useful in the treatment of malignant disease and other hyperplasia |
| 04/19/2001 | DE10030529A1 New ester-cleaving enzyme from Thermomonospora fusca, useful for degrading e.g. polyesters, for recycling or surface modification |
| 04/19/2001 | DE10027695A1 Vaccines against conformation-dependent or non-peptide antigens, based on DNA encoding peptide which mimics the antigen, useful e.g. as antitumor vaccines |
| 04/19/2001 | CA2722337A1 Process for producing ubiquinone-10 |
| 04/19/2001 | CA2718652A1 Process for producing ubiquinone-10 |
| 04/19/2001 | CA2388991A1 Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino |
| 04/19/2001 | CA2388253A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 04/19/2001 | CA2388224A1 Novel c-type lectin and gene thereof |
| 04/19/2001 | CA2387626A1 Viral particles with exogenous internal epitopes |
| 04/19/2001 | CA2387605A1 High yield protein expression system and methods |
| 04/19/2001 | CA2387545A1 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1) |
| 04/19/2001 | CA2387541A1 Short segments of dap-kinase |
| 04/19/2001 | CA2387488A1 Preparation and selection of donor cells for nuclear transplantation |
| 04/19/2001 | CA2387484A1 Adeno-associated virus vectors encoding factor viii and methods of using the same |
| 04/19/2001 | CA2387479A1 Human ldl receptor family proteins and polynucleotides encoding the same |
| 04/19/2001 | CA2387237A1 Novel human potassium channel subunit |
| 04/19/2001 | CA2387231A1 Human galanin family proteins and polynucleotides encoding the same |
| 04/19/2001 | CA2387188A1 Vip54 protein and related materials |
| 04/19/2001 | CA2387184A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | CA2387159A1 Prpp-amidotransferase from plants |
| 04/19/2001 | CA2387148A1 Method for distinguishing 5-position methylation changes |
| 04/19/2001 | CA2387146A1 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 04/19/2001 | CA2387035A1 Methods for generating databases and databases for identifying polymorphic genetic markers |
| 04/19/2001 | CA2386824A1 Methods and compositions for targeting a cell |
| 04/19/2001 | CA2386365A1 Leptin assay |
| 04/19/2001 | CA2386181A1 Converting diploidy to haploidy for genetic diagnosis |
| 04/19/2001 | CA2386177A1 Oculomedin and glaucoma |
| 04/19/2001 | CA2386170A1 Flowering time modification |
| 04/19/2001 | CA2385907A1 Methods to identify compounds that modulate neuronal activity |
| 04/19/2001 | CA2385784A1 Antimicrobial compositions comprising multidrug efflux pumps |
| 04/19/2001 | CA2385196A1 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 04/19/2001 | CA2385172A1 Ab5 toxin b subunit mutants with altered chemical conjugation characteristics |
| 04/19/2001 | CA2385154A1 Atp-binding cassette transporter (abc1) modified transgenic mice |
| 04/19/2001 | CA2385134A1 Template molecule having broad applicability and highly efficient function means of cell-free synthesis of proteins by using the same |
| 04/19/2001 | CA2385123A1 Method of altering polypeptide aggregation |
| 04/19/2001 | CA2384805A1 Recombinant, replication defective celo virus and celo virus dna |
| 04/19/2001 | CA2383969A1 Recombinant megalomicin biosynthetic genes and uses thereof |
| 04/19/2001 | CA2383965A1 Biosynthesis of polyketide synthase substrates |
| 04/19/2001 | CA2383642A1 Anthozoa derived chromophores/fluorophores and methods for using the same |
| 04/19/2001 | CA2382741A1 Methods of producing a target molecule in a transgenic animal and purification of the target molecule |
| 04/19/2001 | CA2382658A1 Process for increasing crop yield or biomass using protoporphyrinogen oxidase gene |
| 04/19/2001 | CA2356953A1 Method for increasing transgenic biomass |
| 04/19/2001 | CA2353801A1 Template-dependent ligation with pna-dna chimeric probes |
| 04/18/2001 | WO2001028685A1 Nucleic acid amplification reaction station for disposable test devices |
| 04/18/2001 | EP1092782A2 Genetic screening method and genetic screening apparatus |
| 04/18/2001 | EP1092780A1 Recombiant, replication defective CELO virus and CELO virus DNA |
| 04/18/2001 | EP1092779A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/18/2001 | EP1092778A1 Agrobacterium-based transformation method for Beta vulgaris |
| 04/18/2001 | EP1092777A1 Self-cleaving RNA sequences and their use for the control of protein synthesis. |
| 04/18/2001 | EP1092776A1 Method for producing L-amino acid by fermentation |
| 04/18/2001 | EP1092775A1 Methods for identifiying non-essential genes of the human cytomegalovirus genome and for screening for inhibitors of human cytomegalovirus |
| 04/18/2001 | EP1092774A2 Borrelia burgdorferi antigen OspA, gene encoding it and uses thereof |
| 04/18/2001 | EP1092773A2 Polypeptide and uses thereof |
| 04/18/2001 | EP1092772A1 Antibody against lar phosphatase subunit |
| 04/18/2001 | EP1092771A2 Tetracycline-regulated transcriptional modulators |
| 04/18/2001 | EP1092770A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 04/18/2001 | EP1092768A1 Conditional gene trapping construct for the disruption of genes |
| 04/18/2001 | EP1092764A2 Continuous fermentation process |
| 04/18/2001 | EP1092727A2 G-protein receptor |
| 04/18/2001 | EP1092725A1 Saccharide transporter |
| 04/18/2001 | EP1092477A1 Method of separation |
| 04/18/2001 | EP1092101A1 Mechanical lock with a cam-driven locking pawl |
| 04/18/2001 | EP1092047A2 Molecular torches |
| 04/18/2001 | EP1092046A1 Methods, compositions and apparatus for making nucleic acid molecules having a selected affinity to a target molecule |
| 04/18/2001 | EP1092045A1 METHOD FOR SIMULTANEOUS IDENTIFICATION OF DIFFERENTIALLY EXPRESSED mRNAs AND MEASUREMENT OF RELATIVE CONCENTRATIONS |